Annual Cash & Cash Equivalents
$14.45 M
-$21.05 M-59.29%
31 December 2023
Summary:
Context Therapeutics annual cash & cash equivalents is currently $14.45 million, with the most recent change of -$21.05 million (-59.29%) on 31 December 2023. During the last 3 years, it has risen by +$14.16 million (+4870.69%). CNTX annual cash & cash equivalents is now -70.89% below its all-time high of $49.64 million, reached on 31 December 2021.CNTX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$84.80 M
-$16.74 M-16.48%
01 September 2024
Summary:
Context Therapeutics quarterly cash and cash equivalents is currently $84.80 million, with the most recent change of -$16.74 million (-16.48%) on 01 September 2024. Over the past year, it has increased by +$63.12 million (+291.21%). CNTX quarterly cash and cash equivalents is now -16.48% below its all-time high of $101.54 million, reached on 30 June 2024.CNTX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CNTX Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -59.3% | +291.2% |
| 3 y3 years | +4870.7% | +10000.0% |
| 5 y5 years | - | - |
CNTX Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -70.9% | +4870.7% | -16.5% | >+9999.0% |
| 5 y | 5 years | -70.9% | +6276.8% | -16.5% | >+9999.0% |
| alltime | all time | -70.9% | +6276.8% | -16.5% | >+9999.0% |
Context Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $84.80 M(-16.5%) |
| June 2024 | - | $101.54 M(+906.4%) |
| Mar 2024 | - | $10.09 M(-30.2%) |
| Dec 2023 | $14.45 M(-59.3%) | $14.45 M(-33.3%) |
| Sept 2023 | - | $21.68 M(-13.8%) |
| June 2023 | - | $25.14 M(-15.6%) |
| Mar 2023 | - | $29.77 M(-16.1%) |
| Dec 2022 | $35.50 M | $35.50 M(-10.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $39.43 M(-8.1%) |
| June 2022 | - | $42.92 M(-6.1%) |
| Mar 2022 | - | $45.73 M(-7.9%) |
| Dec 2021 | $49.64 M(>+9900.0%) | $49.64 M(>+9900.0%) |
| Sept 2021 | - | $419.20 K(-67.2%) |
| June 2021 | - | $1.28 M(-22.9%) |
| Mar 2021 | - | $1.66 M(+471.1%) |
| Dec 2020 | $290.70 K(+28.3%) | $290.70 K |
| Dec 2019 | $226.60 K | - |
FAQ
- What is Context Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Context Therapeutics?
- What is Context Therapeutics annual cash & cash equivalents year-on-year change?
- What is Context Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Context Therapeutics?
- What is Context Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Context Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of CNTX is $14.45 M
What is the all time high annual cash & cash equivalents for Context Therapeutics?
Context Therapeutics all-time high annual cash & cash equivalents is $49.64 M
What is Context Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, CNTX annual cash & cash equivalents has changed by -$21.05 M (-59.29%)
What is Context Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of CNTX is $84.80 M
What is the all time high quarterly cash and cash equivalents for Context Therapeutics?
Context Therapeutics all-time high quarterly cash and cash equivalents is $101.54 M
What is Context Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, CNTX quarterly cash and cash equivalents has changed by +$63.12 M (+291.21%)